Navigation Links
Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference
Date:5/23/2013

SAN DIEGO, May 23, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Deutsche Bank 38th Annual dbAccess Health Care Conference in Boston.  

The live presentation takes place on Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for one month.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Reports First Quarter 2013 Results
2. Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
3. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
4. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
5. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
6. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
7. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
8. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
9. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
10. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2019)... (PRWEB) , ... December 05, ... ... announce its entrance into the Amazon Web Services (AWS) Public Sector Partner ... , The Public Sector Partner program recognizes and collaborates with partners that ...
(Date:12/4/2019)... ... December 04, 2019 , ... Tenex Health, Inc., ... technologies to treat chronic pain in soft and hard tissue, recently achieved a ... , Dr. Bernard Morrey, Chief Medical Officer of Tenex Health, said, ...
(Date:12/2/2019)... (PRWEB) , ... December 02, 2019 , ... Data integration ... companies having access to several internal and external data sources, staff are still working ... A typical trial feasibility analysis can take six weeks or more, and nearly one-third ...
Breaking Medicine Technology:
(Date:12/4/2019)... ... ... While the holidays are a time for joy and sharing, they can ... Service specialists. , “There are many behavioral and logistical changes you ... Joyce Cavanagh, AgriLife Extension specialist in family economics, College Station. , Prioritize and plan ...
(Date:12/4/2019)... ... December 04, 2019 , ... Eolas Therapeutics Inc. ... tobacco use and dependence. The study will investigate safety and pharmacokinetics (PK) of ... of orexin-1 (hypocretin-1) receptors that is being developed in collaboration with AstraZeneca. , ...
(Date:12/2/2019)... ... December 02, 2019 , ... ... worked with EMD Serono, the North American branch of the healthcare business of ... site is designed to educate and inform patients, caregivers, the public, patient advocacy ...
(Date:12/2/2019)... ... December 02, 2019 , ... The Sterling P1000 washer-disinfector ... Processing Department. The elegant design provides a smooth polycarbonate surface that is as ... that allow for manual loading that provides high flexibility and uses very little ...
(Date:11/30/2019)... (PRWEB) , ... November 28, 2019 , ... ... company known for its award-winning cannabis cultivation, production and dispensary operations, has received ... Chocolates™ line of products. , “This is a great accomplishment for our company ...
Breaking Medicine News(10 mins):